• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones

    2023 Contract Manufacturing Survey

    Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges

    A Paradigm Shift for Antioxidants?

    Manufacturing Dietary Supplements in Economic Uncertainty
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    IRI and NPD Rebrand as Circana Following Merger

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision

    Cucumber Extract May Improve Joint Function
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    IRI and NPD Rebrand as Circana Following Merger

    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Intake of Live Microbes from the Diet, Including Fermented Foods, Associated with Better Health
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels

    HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support

    World Economic Forum Names Sofia Elizondo of Brightseed a Young Global Leader

    Intake of Live Microbes from the Diet, Including Fermented Foods, Associated with Better Health

    Cucumber Extract May Improve Joint Function
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Aiya America, Inc. (Aiya Matcha)

    Chenguang Biotech Group Co., Ltd.

    JRS Pharma

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Aiya America, Inc. (Aiya Matcha)

    Chenguang Biotech Group Co., Ltd.

    JRS Pharma

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    FDA Finalizes Guide On Pet Foods Marketed with Disease Claims

    Companies marketing CBD continue to take significant risks from a legal point of view.

    FDA Finalizes Guide On Pet Foods Marketed with Disease Claims
    Todd Harrison, Venable06.01.16
    In May the U.S. Food and Drug Administration (FDA) finalized its Compliance Policy Guide Sec. 690.150 “Labeling and Marketing of Dog and Cat Food Diets Intended to Diagnose, Cure, Mitigate, Treat, or Prevent Diseases” (CPG). FDA had initially issued a draft of this compliance policy guide in September of 2012. 

    The final CPG, like the draft form, makes clear that marketing animal foods with disease claims is technically not permitted and renders the product an adulterated unapproved new drug, while setting forth circumstances that if met will make it less likely for the agency to seek an enforcement action against a company marketing a product with disease claims. Like the draft CPG, the final version also places a great deal of emphasis on the importance of these types of cat and dog foods being marketing only through and under the supervision of veterinarians. 

    Criteria for Enforcement Discretion
    The criteria for enforcement discretion included in the final CPG are generally similar to those included in the draft CPG with the exception of two additional criteria: 1) that the product cannot present a known safety risk when used as labeled; and 2) the product must be manufactured in accordance with cGMPs applicable to animal foods.

    Other key criteria include: 1) distribution of labeling and other communications, and electronic communications bearing disease claims solely to veterinary professionals; 2) general requirement that none of the claims be false or misleading; and 3) a prohibition on the inclusion of any disease claim on the label of the product.

    Key Difference for Pet Supplement Companies
    While the final CPG is similar to the draft, there are a few key differences. Most importantly for pet supplement manufacturers, the final CPG specifically states that the guidance “does not apply to products intended for nutritional supplementation of foods for animals and/or products marketed as dietary supplements for animals.” This CPG now only applies to products that are “labeled and/or marketed to provide all or most of the nutrients in support of meeting the animal’s total daily nutrient requirements by serving as the pet’s sole diet.

    The draft guidance only required that the product be “marketed to provide nutrients in support of meeting the animal’s total daily nutrient requirements.” The draft language left open the possibility that the CPG applied to some animal supplements, however, the final language clearly cuts off that possibility.

    CBD Update
    The cannabidiol (CBD) industry continues to grow at a remarkable pace. Companies marketing CBD products are incredibly diverse and include not only human dietary supplement companies but also pet supplement, vapor and homeopathic drug industries. These companies believe that all of their products are being lawfully marketed and ignore FDA’s warnings to the contrary.

    Indeed, many of the companies simply state that recent warning letters are all about claims and have nothing to do with the ingredient itself. It is true that the first batch of FDA warning letters concentrated on claims, however, the most recent warning letters clearly stated that CBD is not a permissible dietary ingredient. Yet, the same refrain continues about claims. 

    FDA has concluded that CBD products are excluded from the dietary supplement definition under section 201(ff)(3)(B)(ii) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 321(ff)(3)(B)(ii)]. Under that provision, if a substance (such as CBD) has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are outside the definition of a dietary supplement. There is an exception if the substance was “marketed as” a dietary supplement or a conventional food before the new drug investigations were authorized; however, based on available evidence, FDA has concluded that this is not the case for CBD.

    Those marketing CBD take the view that as a constituent of hemp, CBD has been present in the food supply prior to the institution of clinical trials. However, this ignores the plain language of the statute, which states that a new dietary ingredient is exempt from the notification provisions of the Act if it was present in the food supply as an “article” used as food (see FD&C Act § 413).

    It is hemp that is the article of food, not CBD. Indeed, the levels of CBD in hemp are at trace levels similar to the level of mevinolin (the natural form of Lovastatin) in red yeast rice before creating a production process that significantly increased its level in red yeast rice. In that instance, FDA took regulatory action against Pharmanex, stating that the red yeast rice supplement whose manufacturing process has been manipulated to significantly increase its mevinolin content was precluded from being marketed due to the agency’s approval of Lovastatin as a drug. The 10th Circuit Court of appeals ultimately agreed with FDA on its interpretation. Thus, companies marketing CBD continue to take significant risk with their legal position. 

    Regardless, at a minimum, CBD is a new dietary ingredient subject to notification. Again, the red yeast rice scenario is instructive. In that case, FDA argued successfully that the article is not red yeast  rice but the mevinolin, and mevinolin has simply never been used as an article of food. Similarly, CBD has not been used as an article of food and, thus, is subject to the notification to FDA as a new dietary ingredient; and failure to do so causes the ingredient to be adulterated as a matter of law. 

    My opinion is that CBD may be marketed as a dietary ingredient if two conditions are met: 1) it was marketed prior to the filing of the IND and the institution of substantial clinical trials, and 2) a notification is filed. If the CBD industry believes the ingredient is lawfully marketed, it should follow the process and see if FDA refuses to file a notification, and then take the agency to court over the issue. I would only follow this strategy if condition 1) can be satisfied as the Pharmanex red yeast rice case is a major impediment to the argument that hemp is the article of food. Of course, the 10th Circuit is only one appeals court and its jurisdiction is limited, so it’s possible another Circuit Court would have come to a different conclusion.

    Regardless, I believe the case will be litigated at some point, but until that time companies that invest heavily into CBD assets are at risk until the courts resolve the legal status of CBD. 


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Nutrient
    • Nutritional
    • fda
    • labeling
    Related Knowledge Center
    • Dietary Supplements
    • Quality & Safety
    • Healthcare Trends
    • Regulations
    Suggested For You
    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision
    Food Standards Agency Validates Novel Food Applications of Association for the Cannabinoid Industry Food Standards Agency Validates Novel Food Applications of Association for the Cannabinoid Industry
    CENTR Expands Beverage Portfolio with Enhanced Water for Cognitive Function and Mood Support CENTR Expands Beverage Portfolio with Enhanced Water for Cognitive Function and Mood Support
    Naomi Whittel Named O&N Health Board of Directors President Naomi Whittel Named O&N Health Board of Directors President
    Amazon Bans Dietary Supplements Containing NMN Amazon Bans Dietary Supplements Containing NMN
    Common Sense Solutions to Regulating Cannabis and CBD Common Sense Solutions to Regulating Cannabis and CBD
    NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day
    CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway? CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
    Natural Products Association Blasts FDA for Punting CBD Issues to Congress Natural Products Association Blasts FDA for Punting CBD Issues to Congress
    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
    2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy 2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy
    Open Book Extracts and Purissima Announce Study on Cannabinoids and Menstrual Pain Open Book Extracts and Purissima Announce Study on Cannabinoids and Menstrual Pain
    Regulatory Challenges Persist for Dietary Supplement Stakeholders Regulatory Challenges Persist for Dietary Supplement Stakeholders
    Top Trends in CBD: 2022 Market Year in Review Top Trends in CBD: 2022 Market Year in Review
    Formulating for Calm: Drink, Breathe, Relax Formulating for Calm: Drink, Breathe, Relax

    Related Columns

    • Antioxidants | Dietary Supplements | Herbs & Botanicals | Regulations | Regulatory News | Vitamins
      Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision

      Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision

      Increasingly, FDA has used this ‘race to market’ language of DSHEA to prevent or remove safe and legitimate dietary ingredients from commerce.
      By James J. Gormley, Gormley NPI Consulting 03.16.23

    • Breaking News | Herbs & Botanicals | Regulations | Regulatory News | World Markets
      Food Standards Agency Validates Novel Food Applications of Association for the Cannabinoid Industry

      Food Standards Agency Validates Novel Food Applications of Association for the Cannabinoid Industry

      Applications for authorization of CBD isolate and distillate in the UK will now move on to the risk assessment stage to be further assessed.
      03.14.23

    • Cognitive Function | Functional Foods & Beverages | Herbs & Botanicals | Mood Health & Sleep | Proteins, Peptides, Amino Acids
      CENTR Expands Beverage Portfolio with Enhanced Water for Cognitive Function and Mood Support

      CENTR Expands Beverage Portfolio with Enhanced Water for Cognitive Function and Mood Support

      The drinks feature several science-backed ingredients, including citicoline and GABA.
      By Mike Montemarano, Associate Editor 03.07.23


    • Breaking News | Natural/Organic | People News
      Naomi Whittel Named O&N Health Board of Directors President

      Naomi Whittel Named O&N Health Board of Directors President

      Sandra Baek Lee, CEO of NJ Labs, has also been appointed as a new board member.
      03.01.23

    • Dietary Supplements
      Amazon Bans Dietary Supplements Containing NMN

      Amazon Bans Dietary Supplements Containing NMN

      The decision followed FDA’s declaration that the ingredient was first authorized for investigation as a new drug.
      02.16.23

    Loading, Please Wait..
    Trending
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    • HMB And Vitamin D Supplementation Linked To Reduction In Fat Stores
    • Amazon Bans Dietary Supplements Containing NMN
    Breaking News
    • House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients
    • 'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    • IRI and NPD Rebrand as Circana Following Merger
    • ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit
    • HP Ingredients Introduces NuFemme, Herbal Blend for Women’s Hormonal Support
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones
    • Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges
    • 2023 Contract Manufacturing Survey
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • Beyond Antioxidants: The Power of Berries
    • A Paradigm Shift for Antioxidants?
    • Ayana Bio on Path to Scale Bioactives Derived from Plant Cell Cultures
    • Nuritas: Leveraging Artificial Intelligence to Speak the Language of Life
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    IRI and NPD Rebrand as Circana Following Merger
    ABC’s Sustainable Herbs Program Updates Sustainability and Regenerative Practices Toolkit
    Coatings World

    Latest Breaking News From Coatings World

    BASF Invests in Expansion of Polymer Dispersions Plant in Daya Bay, China
    Stahl Completes Acquisition of ICP Industrial Solutions Group
    Interpon Powder Coatings on Dubai’s Latest Luxury Hotel ​
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    David Schnur Associates Adds ERI Group to Its Network of Partners
    BlackHägen Design Promotes Jeff Morang to Director of Human Factors Engineering
    Great Speech Wins First Place at ATA 2023 Innovator’s Challenge
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioNTech, OncoC4 Partner to Develop mAb Candidate ONC-392 in Cancer
    FLAMMA to Invest $200M Over the Next Three Years
    Pii Forms New Leadership Team
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Selena Gomez Becomes Most-Followed Woman on Instagram
    Former Estée Lauder Execs Join Stila Cosmetics' Advisory Board
    Ole Henrikson's Eye Stick is Made from Limestone
    Happi

    Latest Breaking News From Happi

    L’Oréal Invests in Geno-led Venture for Biotech Ingredients
    Saltair Adds Santal Bloom Body Oil to Personal Care Collection
    Fredericksburg Farms Recalls Scented Candles with Glass Lids
    Ink World

    Latest Breaking News From Ink World

    Kodak Reports 4Q, Full-Year 2022 Financial Results
    Fujifilm Releases Uvijet HZ Thermoforming Ink for Acuity Prime Series
    Arkema Bolsters Its CSR Efforts in China
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Schreiner PrinTrust supplies RFID-enabled labels for seventhings
    McDonald’s to publish report on reusable packaging
    Registration opens for FSEA's Print Embellishment Conference
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: TerraCycle Launches Diaper Program, Ahlstrom to Divest or Shutter Stenay Plant & More
    Mativ Names CFO
    Indorama Ventures, Polymateria Partner on Biotransformation Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    NuVasive Receives Expanded Indications for Precice Limb Lengthening Solution
    Alex Jahangir Receives Highest Leadership Award From AAOS
    ODT's Most-Read Stories This Week—March 18
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Second Quarter 2023 Results
    Optomec Mourns Unexpected Loss of CEO Dave Ramahi
    Zebra Technologies Names Rob Armstrong Chief Marketing Officer

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login